Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold

被引：36

作者：

Jones, Eric D. ^{[1
]}

Vandegraaff, Nick ^{[1
]}

Le, Giang ^{[1
]}

Choi, Neil ^{[1
]}

Issa, William ^{[1
]}

Macfarlane, Katherine ^{[1
]}

Thienthong, Neeranat ^{[1
]}

Winfield, Lisa J. ^{[1
]}

Coates, Jonathan A. V. ^{[1
]}

Lu, Long ^{[2
]}

Li, Xinming ^{[2
]}

Feng, Xiao ^{[2
]}

Yu, Changjiang ^{[2
]}

Rhodes, David I. ^{[1
]}

Deadman, John J. ^{[1
]}

机构：

[1] Avexa Ltd, Richmond, Vic 3121, Australia

[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 19期

关键词：

Integrase; Inhibitor; Synthesis; 3-Hydroxy-pyrido[12-a]pyrimidin-4-one;

D O I：

10.1016/j.bmcl.2010.07.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

HIV integrase inhibitors based on a novel bicyclic pyrimidinone core is presented. Nine variations of the core scaffold are evaluated leading to optimization of the 6:6 core giving compound 48 with an EC50 of 3 nM against wild type HIV infected T-cells. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5913 / 5917

页数：5

共 50 条

[11] Design and synthesis of specific inhibitors of the 3′-processing step of HIV-1 integrase
Chi, GC
Seo, BI
Nair, V
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2005, 24 (5-7) : 481 - 484
[12] Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors
Tandon, Vibha
Urvashi
Yaday, Pooja
Sur, Souvik
Abbat, Sheenu
Tiwari, Vinod
Hewer, Raymond
Papathanasopoulos, Maria A.
Raja, Rameez
Banerjea, Akhil C.
Verma, Akhilesh K.
Kukreti, Shrikant
Bharatam, Prasad V.
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (10): : 1065 - 1070
[13] Resistance to HIV-1 integrase inhibitors: A structural perspective
Mouscadet, Jean-Francois
Delelis, Olivier
Marcelin, Anne-Genevieve
Tchertanov, Luba
DRUG RESISTANCE UPDATES, 2010, 13 (4-5) : 139 - 150
[14] Computational studies of HIV-1 integrase and its inhibitors
Nunthaboot, Nadtanet
Pianwanit, Somsak
Parasuk, Vudhichai
Kokpol, Sirirat
Briggs, James M.
CURRENT COMPUTER-AIDED DRUG DESIGN, 2007, 3 (03) : 160 - 190
[15] Synthesis of styrylquinoline carboxamides for HIV-1 integrase inhibitors
Lee, Seung Uk
Park, Jang Hyun
Lee, Jae Yeol
Shin, Cha-Gyun
Chung, Bong Young
Lee, Yong Sup
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2006, 27 (11) : 1888 - 1890
[16] Dipyrimidine-based inhibitors of HIV-1 integrase
Neamati, N
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 289 - 292
[17] Structure Based Drug Design: Clinically Relevant HIV-1 Integrase Inhibitors
Kaur, Maninder
Rawal, Ravindra K.
Rath, Goutam
Goyal, Amit K.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (31) : 2664 - 2680
[18] Novel furocoumarins as potential HIV-1 integrase inhibitors
Olomola, Temitope O.
Mosebi, Salerwe
Klein, Rosalyn
Traut-Johnstone, Telisha
Coates, Judy
Hewer, Raymond
Kaye, Perry T.
BIOORGANIC CHEMISTRY, 2014, 57 : 1 - 4
[19] Structurally diverse HIV-1 integrase inhibitors: Past, present and perspective
Jiang, XH
Long, YQ
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2004, 24 (11) : 1380 - 1388
[20] Structure-based amelioration of PXR transactivation in a novel series of macrocyclic allosteric inhibitors of HIV-1 integrase
Sivaprakasam, Prasanna
Wang, Zhongyu
Meanwell, Nicholas A.
Khan, Javed A.
Langley, David R.
Johnson, Stephen R.
Li, Guo
Pendri, Annapurna
Connolly, Timothy P.
Gao, Mian
Camac, Daniel M.
Klakouski, Cheryl
Zvyaga, Tatyana
Cianci, Christopher
McAuliffe, Brian
Ding, Bo
Discotto, Linda
Krystal, Mark R.
Jenkins, Susan
Peese, Kevin M.
Naidu, B. Narasimhulu
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (22)

← 1 2 3 4 5 →